Niacin Plus Statin to Prevent Vascular Events


Phase 3 Results

Summary of Purpose

The purpose of this study is to determine whether raising "good cholesterol" with a drug based on the vitamin niacin, while lowering "bad cholesterol" with a statin drug, can prevent more heart disease than the statin alone. Trial Stopped: AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 March 2016.

1 Sep 2005 6 Jul 2005 1 Sep 2012 1 Dec 2012 1 Mar 2016 1 Jun 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


  • Ruth McBride